Amkay Products IPO GMP  (Grey Market Premium)

Graphic depicting two circles. In the first circle, half is the Amkay Products logo while the other half reads 'IPO GMP', representing the upcoming IPO's GMP. The second circle contains various medical products, including face masks, alcohol swabs, lancet needles, nebulizers, pulse oximeters, and surgeon caps, representing the medical devices and disposables business profile of the company.

Subscribe  for real-time financial insights on Trade Target’s WhatsApp Channels

Established in October 2007, Amkay Products Limited specializes in producing and distributing various healthcare items like medical devices, disposables, and essentials such as face masks, alcohol swabs, lancet needles, nebulizers, pulse oximeters, and surgeon caps. Their products cater to healthcare centers, hospitals, clinics, and nursing homes across India.

They offer a diverse range of over 30 healthcare products, including respiratory devices, surgical disposables, and home healthcare items. Of these, they manufacture 20 products themselves and trade under their brand name for 10 others. Amkay Products Limited operates two manufacturing units and a warehouse located in Thane, Maharashtra.

Amkay Products IPO Overview

Amkay Products is preparing to go public with an initial public offering worth ₹12.61 crore. The IPO includes 22.92 lakh fresh shares at a face value of  ₹10, priced between ₹52 to  ₹55 per share.

Investors can subscribe to the IPO from April 30, 2024, until May 3, 2024. The company plans to allot shares by May 6, 2024 and aims to list on the BSE SME platform by May 8, 2024.

Before the IPO, the company’s owners, Kashyap Pravin Mody and Himanshu Kantilal Batavia held almost all of the shares 99.89% but their ownership will decrease after the IPO. Bigshare Services Pvt Ltd will handle the IPO registration process.

Racks & Rollers IPO GMP Today (Grey Market Premium)

Click Here
Prime Minister Modi Ji standing with E-Shram Card against teal background

e-SHRAM Card: Eligibility, Benefits and Application Process

Read More
Fundamental Analysis of Tata Elxsi Ltd.

Fundamental Analysis of Tata Elxsi Ltd.

Read More
Yellow triangle with "EPF" against teal background, surrounded by single words: Employee Provident Fund.

What is the Employees Provident Fund or EPF?

Read More

Amkay Products IPO GMP

Let’s look at how Amkay Products's GMP has changed recently.

  • Date: 30 – April – 2024
  • Amkay Products GMP: ₹40 (72.73%)
  • Date: 29 – April – 2024
  • Amkay Products GMP: ₹25 (45.45%)
  • Date: 28 – April – 2024
  • Amkay Products GMP: ₹25 (45.45%)
  • Date: 27 – April – 2024
  • Amkay Products GMP: ₹25 (45.45%)

How to apply for Amkay Products?

For the Amkay Products IPO, retail investors can buy one lot, which includes 2000 shares costing ₹110,000. The maximum retail investor can invest is also one lot, which is the same 2000 shares for ₹110,000. HNI needs to buy at least two lots, which means they will get 4,000 shares costing ₹220,000.

Table displaying the maximum and minimum investments by different investor categories (Retail & HNI) in lot sizes for the Amkay Products.

Amkay Products IPO Financial

Over the past three years, Amkay Products has witnessed remarkable growth in its financial performance. The company’s assets decreased to ₹1,563.77 lakh in 2023 from ₹ 1,580.64 lakh in 2022 but registered a good jump from ₹1,393.47 lakh in 2021. But its PAT continuously decreased from 2021 to 2023 you can check in the below table.

Financial data table for Amkay Products IPO, displaying key figures for the periods ended March 31, 2023, March 31, 2022, and March 31, 2021. The table includes assets in lakh rupees, revenue in lakh rupees, profit after tax (PAT) in lakh rupees, and total borrowing in lakh rupees for each respective period.

Amkay Products IPO Vs Peers

Amkay Products earnings per share or EPS is lower than its peers at 2.37, while Hemant Surgical Industries Ltd has the highest EPS among its peers at 10.28.  And  Qms Medical Allied Services Limited has EPS of 3.9

Comparison of EPS Basic and P/E ratios of Amkay Products Limited, Hemant Surgical Industries Ltd, and Qms Medical Allied Services Limited.

Amkay Products IPO Quota allocation 

  • QIB Investors: 50% of the net issue
  • Retail Investors: 35% of the net issue
  • NII ( HNI ) Investors: 15% of the net issue

Amkay Products IPO Listing Date

  • Subscription Period: 30 April 2024 to 3 May 2024
  • Basis of Allotment Finalization: 6 May 2024
  • Initiation of Refunds: 7 May 2024
  • Demat Credits: 7 May 2024
  • Listing Date: 8 May 2024
  • Listing on: BSE SME
Happy investing and thank you for reading!
Disclaimer: This website content is only for educational purposes, not investment advice. Before making any investment, it’s important to do your own research and be fully informed. Investing in the stock market includes risks, and you should carefully read the Risk Disclosure documents before proceeding. Please remember that past performance doesn’t guarantee future results, and due to market fluctuations, your investment goals may not always be achieved.
Posted in News

Leave a Comment

Your email address will not be published. Required fields are marked *

*
*